全球植入式心臟监视器市场：市场规模、份额和趋势分析（2025-2032 年）

全球植入式心臟监测器市场报告

预计到2025年，全球植入式心臟监测器市场规模将超过13.2亿美元，到2032年将以4.6%的复合年增长率成长，达到近18.1亿美元。这一增长是由对长期心率监测和早期检测心律不整的需求不断增长所驱动的。

本报告沿用范例的结构和调查方法，并针对植入式心臟监测器市场及其具体应用案例进行了客製化。报告详细分析了全球不同地区的销售量、平均售价、手术例数和竞争格局。

在人口老化以及肥胖、糖尿病和其他代谢危险因子日益普遍的背景下，心血管疾病在全球范围内持续上升。全球60岁及以上人口已超过12亿，预计到2030年代初将接近15亿，因此，需要心律不整监测的患者群体正在不断扩大。

市场成长的主要驱动力之一是将人工智慧 (AI) 整合到植入式心臟监视器中。美敦力公司的 AccuRhythm 和雅培公司的 Assert-IQ 等技术透过减少假阳性结果，同时保持对临床重要事件的敏感性，提高了诊断准确性，从而增强了医生的信心，并推动了更广泛的应用。

市场概览

全球植入式心臟监测器市场由用于连续、长期监测心率的植入式设备所组成。这些设备通常用于那些不频繁或原因不明的心律不整患者，对于这类患者，传统的外部监测方法不足以满足需求。

植入式心臟监测器在诊断诸如房颤、晕厥和不明原因中风等疾病方面发挥着至关重要的作用。由于它们可以进行长时间的连续监测，临床医生能够捕捉到一些原本可能被忽略的间歇性事件。

该市场与心血管疾病的发展趋势密切相关。随着老龄化增长和合併症增多，心律不整的盛行率也随之上升，导致长期监测解决方案的需求持续增加。植入式监测器正越来越多地被纳入标准诊断流程，尤其是在有中风或突发心臟事件风险的患者中。

技术进步正在重塑市场格局。设备变得更小巧、更易于植入，更容易与远端监测平台整合。人工智慧演算法的引入提高了诊断准确性，减轻了临床医生的工作量，巩固了植入式心臟监测器作为现代心臟护理重要工具的地位。

市场驱动因素

植入式心臟监测器市场的发展动力源自于降低心血管疾病死亡率的需求。鑑于心血管疾病仍是全球首要死因，早期发现心律不整并启动适当治疗具有重要的临床意义。植入式监测器为识别高风险患者中具有临床意义的事件提供了一种可靠的方法。

心律不整检测和治疗技术的进步也推动了市场成长。随着复杂心律不整治疗方法的改进，精准诊断的价值日益凸显。植入式监测器能够检测出罕见且无症状的心律不整，否则这些心律不整将无法被诊断出来，因此这类设备的使用量不断增加。

人工智慧 (AI) 是最重要的技术驱动力。 AI 驱动的侦测演算法在维持高灵敏度的同时，还能减少误报。这提高了工作流程效率，增强了医生对设备数据的信心，并加速了其在临床环境中的广泛应用。

市场限制

植入式心臟监测器市场的主要阻碍因素是植入手术的高成本。截至2025年，植入手术的总费用通常在10,000美元至15,000美元之间。这意味着即使在拥有医疗保险的已开发国家，手术费用也超出了许多患者的预算。

成本限制也影响新兴市场的普及，因为这些市场的医保报销机制可能无法充分支援植入式监测器的使用。因此，植入式监测器的使用仍集中在高所得地区和专业医疗中心。

另一个限制因素是需要明确的临床证据。虽然植入式监测器能够提供有价值的诊断数据，但其使用必须与成本相权衡。在某些情况下，医生可能会在进行植入手术前选择成本较低的体外监测方法。

市场覆盖范围和数据范围

定量研究范围

市场规模、市占率、市场预测、成长率、销售量、平均售价。

定性研究范围

市场驱动因素和限制因素、成长趋势、竞争分析、併购、公司简介和产品系列。

目标期

基准年：2025 年，历史资料截至 2022 年，预测至 2032 年。

包含的资料类型

销售量、平均售价、治疗次数、市场规模和成长趋势。

目标市场及区隔

本报告涵盖全球植入式心臟监视器市场。

该市场作为一个单一细分市场进行分析，反映了植入式心臟监测技术在整体临床应用中的标准化性质。

所有数据按销售量、平均售价和市场价值分类，并包括 2032 年的预测。

竞争分析

至2025年，美敦力将以其LINQ II和Reveal LINQ系统引领全球植入式心臟监护市场。 LINQ II平台凭藉其先进的AI驱动心律不整侦测和增强的远距监护功能，巩固了美敦力的市场领导地位。 Reveal LINQ系统因其微创设计和成熟的临床性能，在长期监护应用中持续广泛应用。

雅培拥有第二大市场份额，其产品系列包括Confirm Rx、Jot Dx和Assert-IQ等设备。这些系统提供行动数据传输功能和简化的远端监控，从而支援高效的患者管理。雅培整合的基于人工智慧的检测演算法提高了诊断准确性，并增强了公司的竞争优势。

波士顿科学公司凭藉其LUX-Dx植入式心臟监视器占据第三大市场。该设备可提供长期心率监测，并与公司更广泛的心律管理产品组合整合。儘管波士顿科学公司保持稳定的市场地位，但其市场份额仍落后于主要企业。

竞争格局主要集中在少数几家拥有成熟客户关係管理（CRM）产品组合的主要企业之间。竞争的驱动因素包括诊断准确性的提高、设备小型化以及远端监控能力的增强。

技术和临床趋势

人工智慧 (AI) 是影响植入式心臟监测器市场的最重要趋势。 AI 演算法能够提高侦测准确率并减少误报，从而提高设备可靠性并促进临床应用。

小型化技术不断提升患者体验和治疗效率。较小的医疗器材更容易植入，创伤更小，因此应用范围更广。

远端监测也是一个重要的发展趋势。现代设备可自动将资料传输到云端平台，从而实现对患者的持续监测，并减少患者到院进行追踪的需要。

与更广泛的数位医疗系统的整合正在取得进展。植入式监测器正成为互联医疗生态系统的一部分，从而支持对心血管疾病患者进行更全面的管理。

地区

本报告涵盖全球调查区域，包括北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。

本报告包含一份详细的 46 页市场分析、市场区隔和预测。

调查方法附录和简称词彙表。

这份报告的意义

哪些因素推动了全球植入式心臟监测器市场的成长？

人工智慧如何提高诊断的准确性和普及程度？

人口趋势在扩大患者群体中扮演什么角色？

哪些公司在市场中处于领先地位？它们的竞争力如何？

成本和还款的挑战如何影响区域推广？

到 2032 年有哪些成长机会？

iData Research 的《全球植入式心臟监测器市场报告》透过详尽的数据和分析解答了这些问题。利用这份报告，您可以了解市场需求、与竞争对手进行比较，并在蓬勃发展的心臟监测领域制定策略。

目录

图表清单

调查方法

• 第一步：计划启动与团队组建
• 步骤 2：准备资料系统并进行二次调查。
• 步骤 3：设计和准备访谈和调查问卷。
• 第四步：进行初步调查
• 第五步：调查与分析：建立基准估计值
• 第六步：市场预测与分析
• 步骤 7：辨识策略机会
• 步骤 8：最终审核和市场推广
• 步骤九：客户回馈与市场监测

全球关税的影响

植入式心臟监测器市场

• 全球植入式心臟监测器市场概览
• 竞争分析
• 目标区域

介绍

手术次数

市场分析与预测

促进因素和抑制因素

竞争性市占率分析

简称

Global Insertable Cardiac Monitor Market Report

The global insertable cardiac monitor market was valued at over $1.32 billion in 2025 and is expected to grow at a CAGR of 4.6% to reach nearly $1.81 billion by 2032. Growth is supported by increasing demand for long-term cardiac rhythm monitoring and earlier detection of arrhythmias.

This report follows the same structure and methodology as the provided example, adapted to the insertable cardiac monitor market and its specific clinical use cases . It includes detailed analysis of unit sales, average selling prices, procedural volumes and competitive positioning across global regions.

Cardiovascular disease continues to rise globally, driven by aging populations and increasing prevalence of obesity, diabetes and other metabolic risk factors. The global population over 60 has surpassed 1.2 billion and is expected to approach 1.5 billion by the early 2030s, expanding the patient base for arrhythmia monitoring.

A key driver of market growth is the integration of artificial intelligence into insertable cardiac monitors. Technologies such as Medtronic's AccuRhythm and Abbott's Assert-IQ improve diagnostic accuracy by reducing false positives while maintaining sensitivity to clinically significant events, increasing physician confidence and supporting broader adoption.

Market Overview

The global insertable cardiac monitor market consists of implantable devices designed for continuous, long-term monitoring of cardiac rhythm. These devices are typically used in patients with infrequent or unexplained arrhythmias, where traditional external monitoring methods are insufficient.

Insertable cardiac monitors play a critical role in diagnosing conditions such as atrial fibrillation, syncope and cryptogenic stroke. Their ability to provide continuous monitoring over extended periods allows clinicians to capture intermittent events that would otherwise go undetected.

The market is closely tied to trends in cardiovascular disease. As the prevalence of arrhythmias increases with age and comorbid conditions, demand for long-term monitoring solutions continues to grow. Insertable monitors are increasingly used as part of standard diagnostic pathways, particularly in patients at risk of stroke or sudden cardiac events.

Technological advancements are reshaping the market. Devices are becoming smaller, easier to implant and more integrated with remote monitoring platforms. The addition of AI-driven algorithms is improving diagnostic accuracy and reducing clinician workload, positioning insertable cardiac monitors as a key tool in modern cardiac care.

Market Drivers

The insertable cardiac monitor market is driven by the need to reduce mortality associated with cardiovascular disease. With cardiovascular disease remaining the leading cause of death globally, there is strong clinical incentive to detect arrhythmias earlier and initiate appropriate treatment. Insertable monitors provide a reliable method for identifying clinically significant events in high-risk patients.

Advances in arrhythmia detection and treatment are also supporting market growth. As therapies for complex arrhythmias improve, the value of accurate diagnosis increases. Insertable monitors enable detection of infrequent or asymptomatic arrhythmias, which would otherwise remain undiagnosed, leading to increased utilization of these devices.

Artificial intelligence represents the most significant technological driver. AI-enabled detection algorithms reduce false positive alerts while maintaining high sensitivity. This improves workflow efficiency and increases physician confidence in device data, supporting broader adoption across clinical settings.

Market Limiters

The primary limitation of the insertable cardiac monitor market is the high cost of implantation procedures. In 2025, the total cost of an implantation procedure typically ranged from $10,000 to $15,000. This places the procedure outside the budget of many patients, even in developed markets with insurance coverage.

Cost constraints also impact adoption in emerging markets, where reimbursement systems may not fully support the use of insertable monitors. As a result, utilization remains concentrated in higher-income regions and specialized care centers.

Another limitation is the need for clear clinical justification. While insertable monitors provide valuable diagnostic data, their use must be balanced against cost considerations. In some cases, physicians may opt for less expensive external monitoring methods before proceeding to implantation.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, growth rates, units sold and average selling prices.

Qualitative Coverage

Market drivers and limiters, growth trends, competitive analysis, mergers and acquisitions, company profiles and product portfolios.

Time Frame

Base year 2025, historical data to 2022 and forecasts through 2032.

Data Types Included

Unit sales, average selling prices, procedure numbers, market size and growth trends.

Markets Covered and Segmentation

The report covers the Global Insertable Cardiac Monitor Market.

The market is analyzed as a unified segment, reflecting the standardized nature of insertable cardiac monitor technology across clinical applications.

All data is segmented by unit volume, average selling price and market value, with forecasts through 2032.

Competitive Analysis

Medtronic leads the global insertable cardiac monitor market in 2025, supported by its LINQ II and Reveal LINQ systems. The LINQ II platform incorporates advanced AI-driven arrhythmia detection and enhanced remote monitoring capabilities, strengthening Medtronic's position as the market leader. The Reveal LINQ remains widely used for long-term monitoring due to its minimally invasive design and established clinical performance.

Abbott holds the second-leading position with a portfolio that includes Confirm Rx, Jot Dx and Assert-IQ devices. These systems offer mobile-enabled data transmission and streamlined remote monitoring, supporting efficient patient management. Abbott's integration of AI-based detection algorithms has improved diagnostic accuracy and strengthened its competitive position.

Boston Scientific ranks third in the market with its LUX-Dx insertable cardiac monitor. The device provides long-term rhythm monitoring and integrates with the company's broader cardiac rhythm management portfolio. While Boston Scientific maintains a stable position, its market share remains behind the leading competitors.

The competitive landscape is concentrated among a small number of major players with established CRM portfolios. Competition is driven by improvements in diagnostic accuracy, device miniaturization and remote monitoring capabilities.

Technology and Practice Trends

Artificial intelligence is the most important trend shaping the insertable cardiac monitor market. AI-driven algorithms improve detection accuracy and reduce false positive alerts, making devices more reliable and easier to use in clinical practice.

Miniaturization continues to improve patient experience and procedural efficiency. Smaller devices are easier to implant and less invasive, supporting wider adoption.

Remote monitoring is also a key trend. Modern devices transmit data automatically to cloud-based platforms, enabling continuous patient monitoring and reducing the need for in-person follow-up visits.

Integration with broader digital health systems is increasing. Insertable monitors are becoming part of connected care ecosystems, supporting more comprehensive management of cardiovascular patients.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

46 pages of detailed market analysis, segmentation and forecasts.

Methodology Appendix and Acronym Glossary.

Why This Report

What is driving growth in the global insertable cardiac monitor market?

How is artificial intelligence improving diagnostic accuracy and adoption?

What role do demographic trends play in expanding the patient base?

Which companies lead the market and how strong are their competitive positions?

How do cost and reimbursement challenges impact adoption across regions?

What are the key opportunities for growth through 2032?

The Global Insertable Cardiac Monitor Market Report from iData Research answers these questions with detailed data and analysis. Use it to understand demand, benchmark competitors and plan strategy in a growing segment of cardiac monitoring.

TABLE OF CONTENT

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Insertable Cardiac Monitor Market

• 8.1.1 Global Insertable Cardiac Monitor Market Overview
• 8.1.2 Competitive Analysis
• 8.1.3 Regions Included

Introduction

Procedure Numbers

Market Analysis And Forecast

Drivers And Limiters

• 8.1.4 Market Drivers
• 8.1.5 Market Limiters

Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 8-1: Insertable Cardiac Monitor Market, Global, 2022 - 2032
• Chart 8-2: Insertable Cardiac Monitor Placement Procedures, Global, 2025
• Chart 8-3: Insertable Cardiac Monitor Placement Procedures by Region, Global, 2022 - 2032
• Chart 8-4: Insertable Cardiac Monitor Device Market, Global, 2022 - 2032
• Chart 8-5: Leading Competitors, Insertable Cardiac Monitor Market, Global, 2025

LIST OF FIGURES

• Figure 8-1: Insertable Cardiac Monitor Regions Covered, Global (1 of 2)
• Figure 8-2: Insertable Cardiac Monitor Regions Covered, Global (2 of 2)
• Figure 8-3: Insertable Cardiac Monitor Placement Procedures by Region, Global, 2022 - 2032
• Figure 8-4: Insertable Cardiac Monitor Placement Procedures by Country, North America, 2022 - 2032
• Figure 8-5: Insertable Cardiac Monitor Placement Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 8-6: Insertable Cardiac Monitor Placement Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 8-7: Insertable Cardiac Monitor Placement Procedures by Country, Western Europe, 2022 - 2032
• Figure 8-8: Insertable Cardiac Monitor Placement Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 8-9: Insertable Cardiac Monitor Placement Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 8-10: Insertable Cardiac Monitor Placement Procedures by Country, Middle East, 2022 - 2032
• Figure 8-11: Insertable Cardiac Monitor Placement Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 8-12: Insertable Cardiac Monitor Placement Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 8-13: Insertable Cardiac Monitor Placement Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 8-14: Insertable Cardiac Monitor Placement Procedures by Country, Africa, 2022 - 2032
• Figure 8-15: Insertable Cardiac Monitor Market, Global, 2022 - 2032
• Figure 8-16: Units Sold by Region, Insertable Cardiac Monitor Market, Global, 2022 - 2032
• Figure 8-17: Average Selling Price by Region, Insertable Cardiac Monitor Market, Global, 2022 - 2032 (US$)
• Figure 8-18: Market Value by Region, Insertable Cardiac Monitor Market, Global, 2022 - 2032 (US$M)
• Figure 8-19: Leading Competitors, Insertable Cardiac Monitor Market, Global, 2025